sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 1348.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>

Public Release: 11-Jan-2017
Proceedings of the National Academy of Sciences
Study finds vaccination is the most cost-effective way to reduce rabies deaths in India
Every year in India, about 20,000 people die from rabies. Most of the victims are children. Nearly all of the deaths occur after victims are bitten by rabid dogs. For years, experts have debated the best strategy to reduce this burden. Now, a new study has identified a cost-effective way to reduce death due to rabies.

Contact: David Kohn
dkohn@som.umaryland.edu
410-706-7590
University of Maryland School of Medicine

Public Release: 11-Jan-2017
Analytical Chemistry
DNA duplicator small enough to hold in your hand
Vanderbilt engineers have developed a new method for duplicating DNA that makes devices small enough to hold in your hand that are capable of identifying infectious agents before symptoms appear.
Bill & Melinda Gates Foundation's Grand Challenges in Global Health Initiative in Diagnostics, Vanderbilt-Zambia Network for Innovation in Global Health Technologies, National Institutes of Health

Contact: David F. Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University

Public Release: 11-Jan-2017
WPI researcher wins NSF CAREER Award to study how bacteria survive in stressful conditions
With a five-year, $1.1 million CAREER Award from the National Science Foundation (NSF), Scarlett Shell at Worcester Polytechnic Institute (WPI) will study the molecular mechanisms that enable bacteria to endure starvation, lack of oxygen, and other hostile conditions, work that could have a broad impact in a number of fields and provide clues for treatments for infectious diseases, including multi-drug resistant strains of tuberculosis, a major global health threat
National Science Foundation

Contact: Michael Cohen
mcohen@wpi.edu
508-868-4778
Worcester Polytechnic Institute

Public Release: 10-Jan-2017
Journal of Pediatrics
Nothing fishy about better nutrition for mums and babies
Researchers from the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have found a way to provide mothers and young children in Cambodia with better nutrition through an unlikely source -- fish sauce.

Contact: Professor Tim Green
tim.green@sahmri.com
University of Adelaide

Public Release: 9-Jan-2017
Canadian Medical Association Journal
Recognize sepsis as a separate cause of illness and death
Sepsis should be recognized as a separate cause of illness and death around the world. This focus would help efforts to prevent sepsis by improving hygiene, nutrition and vaccination rates and also lead to timely treatment, better outcomes and quality of life for people with sepsis, argue researchers in a commentary in CMAJ.

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
800-267-9703
Canadian Medical Association Journal

Public Release: 5-Jan-2017
EBioMedicine
Anemia protects African children against malaria
Researchers have found iron deficiency anemia protects children against the blood-stage of Plasmodium falciparum malaria in Africa, and treating anemia with iron supplementation removes this protective effect.
Bill and Melinda Gates Foundation

Contact: Morag MacLachlan
morag_maclachlan@med.unc.edu
919-843-5719
University of North Carolina Health Care

Public Release: 5-Jan-2017
Scientific Reports
Researcher turns 'SARS mask' into a virus killer
The surgical masks people wear to stop the spread of diseases don't work well -- that isn't what they're designed for. Pathogens like influenza are transmitted in aerosol droplets when we cough or sneeze. Masks trap the droplets but the virus remains infectious. Hyo-Jick Choi, an engineering professor at the University of Alberta, took on the challenge of improving the masks, using salt to turn them into virus killers.
University of Alberta

Contact: Richard Cairney
richard.cairney@ualberta.ca
780-492-4514
University of Alberta

Public Release: 5-Jan-2017
UNC Catalyst initiative aims to create, share tools to fight rare diseases
The University of North Carolina at Chapel Hill has launched UNC Catlayst with a $2 million grant from the Eshelman Institute for Innovation. The initiative will provide patient groups and rare-disease organizations with the knowledge and research tools to train scientists to create new treatments.
Eshelman Institute for Innovation at UNC-Chapel HIll

Contact: Thania Benios
thania_benios@unc.edu
917-930-5988
University of North Carolina at Chapel Hill

Public Release: 5-Jan-2017
PLOS Neglected Tropical Diseases
Medical screening and fly control could rapidly reduce sleeping sickness in key locations
In 2012, the World Health Organization set public health goals for reducing Gambian sleeping sickness, a parasitic infection. Now, by mathematically modeling the impact of different intervention strategies, researchers reporting in PLOS Neglected Tropical Diseases have described how two-pronged approaches, integrating medical intervention and vector control, could substantially speed up the elimination of sleeping sickness in high burden areas of the Democratic Republic of Congo.

Contact: Luke Walton
L.Walton.1@warwick.ac.uk
PLOS

Public Release: 5-Jan-2017
PLOS Pathogens
Potential evidence of lung-specific Ebola infection found in recovering patient
Scientists have found potential evidence of Ebola virus replication in the lungs of a person recovering from infection, according to new research published in PLOS Pathogens. The findings could aid research into new treatment approaches and better understanding of how the virus is transmitted.

Contact: Giuseppe Ippolito
giuseppe.ippolito@inmi.it
PLOS

Public Release: 4-Jan-2017
Specific Technologies announces new results and a major new NIAID grant award
Specific Technologies today announces development of a new paradigm for the quantitative determination of antibiotic efficacy.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Press Office
press@specifictechnologies.net
650-938-2030
Specific Technologies

Public Release: 4-Jan-2017
None
MSU lands $1 million USAID grant to fight Zika
Michigan State University has landed a highly competitive grant from USAID to fight the Zika virus in Mexico.
US Agency for International Development

Contact: Layne Cameron
layne.cameron@cabs.msu.edu
517-353-8819
Michigan State University

Public Release: 3-Jan-2017
American Journal of Clinical Nutrition
Zinc eaten at levels found in biofortified crops reduces 'wear and tear' on DNA
A new study by researchers from the UCSF Benioff Children's Hospital Research Institute (CHORI) shows that a modest 4 milligrams of extra zinc a day in the diet can have a profound, positive impact on cellular health that helps fight infections and diseases. This amount of zinc is equivalent to what biofortified crops like zinc rice and zinc wheat can add to the diet of vulnerable, nutrient deficient populations.

Contact: Melinda Krigel
mkrigel@mail.cho.org
510-428-3069
Children's Hospital & Research Center Oakland

Public Release: 3-Jan-2017
Journal of Medical Entomology
Why odds are against a large Zika outbreak in the US
Is the United States at risk for a large-scale outbreak of Zika or other mosquito-borne disease? While climate conditions in the US are increasingly favorable to mosquitos, socioeconomic factors such as access to clean water and air conditioning make large-scale outbreaks unlikely, according to new analysis of existing research -- but small-scale, localized outbreaks are an ongoing concern.
Indiana University-Purdue, University Indianapolis Chancellor for Research

Contact: Joe Rominiecki
jrominiecki@entsoc.org
301-731-4535 x3009
Entomological Society of America

Public Release: 2-Jan-2017
Current Drug Targets
Targeting legumain as a novel therapeutic strategy in cancers
This review will be the first to summarize the expression of legumain (LGMN) in common cancers, as well as its roles in tumourigenesis and metastasis. This review also discusses the current developments and future prospects of targeting LGMN through the development of DNA vaccines, azo-peptides, small molecule inhibitors and LGMN activated prodrugs, highlighting the potential of LGMN as a target for cancer therapeutics.

Contact: Faizan ul Haq
faizan@benthamscience.org
Bentham Science Publishers

Public Release: 2-Jan-2017
Proceedings of the National Academy of Sciences
For the first time, researchers identify key proteins that may make Zika so deadly
Now, a new study has for the first time identified seven key proteins in the virus that may be the culprits behind this damage. The study is the first comprehensive description of the Zika virus genome.

Contact: David Kohn
dkohn@som.umaryland.eduh
410-706-7590
University of Maryland School of Medicine

Public Release: 22-Dec-2016
Specific Technologies and FIND announce strategic collaboration
Specific Technologies and FIND today announced a collaboration to promote the development of new solutions for diagnosis of bloodstream infections in resource-poor environments.

Contact: Press Contact
press@specifictechnologies.net
650-938-2030
Specific Technologies

Public Release: 22-Dec-2016
PLOS Neglected Tropical Diseases
Deadly sleeping sickness set to be eliminated in 6 years
Gambian sleeping sickness -- a deadly parasitic disease spread by tsetse flies -- could be eliminated in six years in key regions in the Democratic Republic of Congo (DRC), according to new research by the University of Warwick.
Bill and Melinda Gates Foundation, Task Force for Global Health, Biotechnology and Biological Sciences Research Council, Department for International Development, The Economic & Social Science Research Council, The Natural Environment Research Council

Contact: Luke Walton
L.Walton.1@warwick.ac.uk
44-782-454-0863
University of Warwick

Public Release: 21-Dec-2016
Neurology
Challenges remain in HIV care in Africa
Barriers to diagnosis and lack of access to modern medications have combined to place caregivers and HIV-positive patients in sub-Saharan Africa between a rock and a hard place. A new study shows that physicians are often forced to choose between controlling seizures, which can occur if the disease goes undiagnosed for too long, or treating the underlying HIV infection.
Fogarty International Center and NIH/National Institute of Neurological Disorders and Stroke

Contact: Mark Michaud
mark_michaud@urmc.rochester.edu
585-273-4790
University of Rochester Medical Center

Public Release: 20-Dec-2016
NIH launches first large trial of a long-acting injectable drug for HIV prevention
The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today. The study, sponsored by NIH, will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every 8 weeks can safely protect men and transgender women from HIV infection at least as well as the anti-HIV medication Truvada taken daily as an oral tablet.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Laura S. Leifman
laura.sivitz@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 19-Dec-2016
Applied and Environmental Microbiology
DNA markers distinguish between harmless, deadly bacteria
Through a new study of the coccobacillus Francisella, Los Alamos National Laboratory researchers are working to use DNA markers to discern related but relatively harmless species as they are identified and to provide a means to distinguish them from the harmful F. tularensis.
US Department of Homeland Security, Science and Technology Directorate

Contact: Nancy Ambrosiano
nwa@lanl.gov
505-667-0471
DOE/Los Alamos National Laboratory

Public Release: 19-Dec-2016
Nature Chemical Biology
Ancient Chinese malaria remedy fights TB
A centuries-old herbal medicine, discovered by Chinese scientists and used to effectively treat malaria, has been found to potentially aid in the treatment of tuberculosis and may slow the evolution of drug resistance. In a promising study led by Robert Abramovitch, a Michigan State University microbiologist and TB expert, the ancient remedy artemisinin stopped the ability of TB-causing bacteria, known as Mycobacterium tuberculosis, to become dormant. The study is published in the journal Nature Chemical Biology.
Bill and Melinda Gates Foundation, National Institutes of Health, MSU AgBioResearch

Contact: Sarina Gleason
sarina.gleason@cabs.msu.edu
517-355-9742
Michigan State University

Public Release: 16-Dec-2016
The Lancet
Children dying preventable deaths from congenital heart disease
Over one million children are born with congenital heart disease (CHD) each year, and 90 percent are born in poor regions with little or no access to care. CHD and other serious birth defects are among the top five causes of death of children worldwide. Increasing access to care will save children's lives.

Contact: Faith Adams
faith@childrensheartlink.org
612-423-7125
Children's HeartLink

Public Release: 15-Dec-2016
Scientific Reports
UCLA researchers combat antimicrobial resistance using smartphones
A team of UCLA researchers has developed an automated diagnostic test reader for antimicrobial resistance using a smartphone. The technology could lead to routine testing for antimicrobial susceptibility in areas with limited resources.

Contact: Matthew Chin
mchin@support.ucla.edu
310-206-0680
University of California - Los Angeles

Public Release: 15-Dec-2016
Funding for new treatments for malnourished children
A consortium of researchers including groups from Plymouth University, University College London and Queen Mary University of London have received funding from the Medical Research Council-led Foundation Award with support from the Biotechnology and Biological Sciences Research Council to assess new ways to help severely malnourished children in Zambia and Zimbabwe.
Global Challenges Research Fund

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth

Showing releases 101-125 out of 1348.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>